EA200301271A1 - Способ диагностики или прогнозирования основных респираторных бактериальных патогенов у субъекта - Google Patents

Способ диагностики или прогнозирования основных респираторных бактериальных патогенов у субъекта

Info

Publication number
EA200301271A1
EA200301271A1 EA200301271A EA200301271A EA200301271A1 EA 200301271 A1 EA200301271 A1 EA 200301271A1 EA 200301271 A EA200301271 A EA 200301271A EA 200301271 A EA200301271 A EA 200301271A EA 200301271 A1 EA200301271 A1 EA 200301271A1
Authority
EA
Eurasian Patent Office
Prior art keywords
subject
pathogenes
prediction
diagnostic
iii
Prior art date
Application number
EA200301271A
Other languages
English (en)
Other versions
EA005776B1 (ru
Inventor
Йеспер Эуген-Ольсен
Original Assignee
Вайрогейтс Апс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вайрогейтс Апс filed Critical Вайрогейтс Апс
Publication of EA200301271A1 publication Critical patent/EA200301271A1/ru
Publication of EA005776B1 publication Critical patent/EA005776B1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Способ диагностики и/или прогнозирования респираторных бактериальных инфекций у субъекта, предусматривающий стадии (a) выполнения in vitro измерения уровня одного или нескольких маркеров в форме (i) рецептора урокиназного активатора плазминогена (uPAR), (ii) растворимого рецептора урокиназного активатора плазминогена (suPAR) и/или (iii) одного или нескольких продуктов деградации (i) или (ii) в пробе биологической жидкости от субъекта и (b) использования полученной величины измерения для оценки состояния субъекта. В частности, могут быть диагностированы и/или прогнозированы инфекции Streptococcus pneumoniae и Mycobacterium tuberculosis.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200301271A 2001-05-18 2002-05-21 Способ диагностики или прогнозирования основных респираторных бактериальных патогенов у субъекта EA005776B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100799 2001-05-18
PCT/DK2002/000341 WO2002095411A1 (en) 2001-05-18 2002-05-21 A method of diagnosing or prognosticating major respiratory bacterial pathogens in a subject

Publications (2)

Publication Number Publication Date
EA200301271A1 true EA200301271A1 (ru) 2004-06-24
EA005776B1 EA005776B1 (ru) 2005-06-30

Family

ID=8160511

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200301271A EA005776B1 (ru) 2001-05-18 2002-05-21 Способ диагностики или прогнозирования основных респираторных бактериальных патогенов у субъекта

Country Status (11)

Country Link
US (1) US7399602B2 (ru)
EP (1) EP1405076B1 (ru)
CN (1) CN100340858C (ru)
AT (1) ATE479097T1 (ru)
BR (1) BRPI0210903B8 (ru)
DE (1) DE60237448D1 (ru)
DK (1) DK1405076T3 (ru)
EA (1) EA005776B1 (ru)
ES (1) ES2351690T3 (ru)
WO (1) WO2002095411A1 (ru)
ZA (1) ZA200309770B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001038871A1 (en) 1999-11-25 2001-05-31 Eugen Olsen Jesper A method of diagnosing or prognosticating hiv infection in a subject
US20060084184A1 (en) * 2004-10-19 2006-04-20 Renovar Incorporated Reagents for urine-based immunological assays
JP4943515B2 (ja) * 2007-12-28 2012-05-30 株式会社ビーエル 結核菌群の免疫検出法
CN103635805B (zh) 2011-05-19 2016-03-02 持田制药株式会社 使用尿样本的呼吸道传染病的诊断
GB201211982D0 (en) * 2012-07-05 2012-08-22 Isis Innovation Biomarker
WO2015159239A1 (en) * 2014-04-15 2015-10-22 Stellenbosch University A method for diagnosing tuberculous meningitis
EP3177312B1 (en) * 2014-08-08 2020-12-30 Randox Laboratories Ltd. Method and kit for detecting bacterial infection
CN106556703A (zh) * 2016-10-18 2017-04-05 上海凯璟生物科技有限公司 一种慢性肾脏病标志物suPAR检测试剂盒和制备方法
RU2659384C1 (ru) * 2017-07-10 2018-06-29 Федеральное государственное бюджетное учреждение "Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства" Способ раннего прогнозирования характера течения острой респираторной инфекции у детей
GB201802795D0 (en) * 2018-02-21 2018-04-04 Virogates As Patient assessment method
FR3080185A1 (fr) * 2018-04-16 2019-10-18 Biomerieux Evaluation du risque de complication chez un patient suspecte d'avoir une infection ayant un score sofa inferieur a deux
EP4133282A1 (en) * 2020-04-08 2023-02-15 ViroGates A/S Sars-cov-2 infection risk assessment method
RU2765744C2 (ru) * 2020-07-20 2022-02-02 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) Способ определения вероятности летального исхода на основании жалоб у больного туберкулезом с ВИЧ-инфекцией при поступлении в стационар Федеральной службы исполнения наказаний РФ
CN113295874B (zh) * 2021-05-25 2022-03-04 广东源心再生医学有限公司 一种用于瓣膜性心脏病辅助诊断的新型标志物、辅助诊断的产品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845026A (en) * 1985-12-03 1989-07-04 T Cell Sciences, Inc. Assay systems for detecting cell-free T cell antigen receptor related molecules and the clinical utilities of the assays
US5459078A (en) * 1988-01-29 1995-10-17 Abbott Laboratories Methods and reagents for performing ion-capture digoxin assays
AU752143B2 (en) 1998-01-26 2002-09-05 Biotech Australia Pty Limited PAI-2 and t-PA as diagnostic markers of periodontal disease
US6077508A (en) * 1998-03-23 2000-06-20 American Diagnostica Inc. Urokinase plasminogen activator receptor as a target for diagnosis of metastases
DE19840671A1 (de) 1998-08-26 2000-03-02 Stiftung Tumorbank Basel Verfahren zur Diagnose von Rezidiven bei nodal-negativem Brustkrebs
CA2384295A1 (en) 1999-04-28 2000-11-02 Yahia Gawad Method for determining plasminogen activator inhibitor
WO2001038871A1 (en) 1999-11-25 2001-05-31 Eugen Olsen Jesper A method of diagnosing or prognosticating hiv infection in a subject

Also Published As

Publication number Publication date
US20050100961A1 (en) 2005-05-12
US7399602B2 (en) 2008-07-15
BR0210903A (pt) 2004-06-08
BRPI0210903B8 (pt) 2021-07-27
EP1405076A1 (en) 2004-04-07
BRPI0210903B1 (pt) 2017-01-17
DE60237448D1 (de) 2010-10-07
EA005776B1 (ru) 2005-06-30
ES2351690T3 (es) 2011-02-09
ATE479097T1 (de) 2010-09-15
CN100340858C (zh) 2007-10-03
DK1405076T3 (da) 2011-01-03
EP1405076B1 (en) 2010-08-25
WO2002095411A1 (en) 2002-11-28
ZA200309770B (en) 2004-09-28
CN1723394A (zh) 2006-01-18

Similar Documents

Publication Publication Date Title
EA200301271A1 (ru) Способ диагностики или прогнозирования основных респираторных бактериальных патогенов у субъекта
AU2002341191A1 (en) Diagnosis of clinical infection of a wound
GB2461410A (en) Soluble urokinase plasminogen activator receptor (SUPAR) as marker for diseases
AU2002327308A1 (en) Methods for evaluating pathologic conditions using extracellular rna
DE60130373D1 (de) Messstreifenspenderanordnung
SE0102919D0 (sv) Medical device
ATE120757T1 (de) Diagnostischer test für plasminogenaktivatoren vom gewebs- und urokinasetyp und dafür kodierende gene.
AP1623A (en) A method of diagnosing of prognosticating HIV infection in a subject.
SE0100195D0 (sv) Utvärderingsförfaranden för antitumöraktivitet
Hobbs et al. The effect of supervised exercise and cilostazol on coagulation and fibrinolysis in intermittent claudication: a randomized controlled trial
HK1059038A1 (en) Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression
DK1611252T3 (da) In vitro-fremgangsmåde til påvisning af overgangscelle-karcinom i blæren
AU2002367317A1 (en) Psoriasin expression by breast epithelial cells
NO20003766L (no) PAI-2 og t-PA som diagnostiske markører for periodontal sykdom
WO2005087917A8 (en) Enzyme and preparation method
DE60232069D1 (de) Formen prostataspezifischer antigene und verfahren zu deren nachweis
GB0121054D0 (en) A method for the measurement of post arteriolar pressure
WO2002056666A3 (en) A method of detecting ultrasound contrast agent in soft tissue, and quantitating blood perfusion through regions of tissue
DE60144027D1 (de) 5t4 rna in plasma und serum als marker für neoplastische erkrankungen
DE50311184D1 (de) EG-VEGF/Prokineticin 2 Rezeptor Antagonisten
ATE370243T1 (de) Screeningverfahren für einen auf die zellwand wirkenden arzneistoff
WILL et al. Expression of urokinase-type plasminogen-activator (uPA) and Its receptor (uPAR) in human ovarian-cancer cells and in-vitro invasion capacity
MXPA03009138A (es) Produccion de anticuerpos monoespecificos policlonales, contra variantes del receptor activador del plasminogeno de tipo uroquinasa (upar) del4, del5 y del4+5 y su uso para propositos de diagnostico y terapeutico.
WO2001042488A3 (en) Plasminogen activator assay involving an elastase inhibitor
GB0024641D0 (en) Apparatus & method for observing changes in biological structures

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KZ RU